Infectious Diseases and HIV Conference

Respiratory tract infections are among the leading medical morbidity and mortality worldwide and affect all age groups.

The session is intended to present an overview of RTIs, encompassing the epidemiology of such infections, their clinical features, diagnostic dilemmas, and advances made in their management over the most recent times.RTIs can be broadly categorized into two, which include the URIs and the LRIs.

Amongst the URIs are included simple common cold and pharyngitis, sinusitis, while among the LRIs are pneumonia, bronchitis and bronchiolitis. All the different pathogens that cause these infections will be discussed in this lecture; including: - Bacteria: the Streptococcus pneumonia and Hemophilic influenza - Viruses: including influenza and SARS-CoV-2 - Atypical organisms: including Mycoplasma pneumoniae.Epidemiology of RTIs mandates public health approaches.

The session will be discussing at what risks patients run with age, comorbidity, environmental factors and vaccination status. Participants will be made aware of diseases and burden across the globe and how outbreaks as such as the most recent one, the COVID-19 pandemic have accounted for an impact on healthcare systems. Rapid and accurate diagnosis is, therefore, critical for effective management of RTIs.

Clinical evaluation, imaging studies, and laboratory testing are important contributors towards differential diagnosis between viral and bacterial infections. Rapid diagnostic tests and biomarkers are gaining prominence in clinical practices for improving diagnostic accuracy and informing treatment choices. The treatment approaches applied to RTIs depend on the etiology and severity of the infection.

The participants will also learn about contemporary management protocols for bacterial pneumonia, viral bronchitis, and other RTIs, which may include the judicious use of antibiotics and antiviral drugs. Adequate supportive therapy, immunization, and preventive measures will further be highlighted, especially among susceptible populations.

We will focus more on the developing problem of antimicrobial resistance in respiratory infections and the call for stewardship programs for optimal use of antibiotics.

We must be able to enhance our response to respiratory tract infections by the healthcare professionals with researchers and public health officials toward better patient outcomes.

Join us with a panel of leaders in the field as we dissect the complexities and nuances involved with respiratory tract infections as we drive forward to more accurate diagnosis and treatment.